Bioceltix S.A. discloses major shareholders following resumed General Meeting

Bioceltix S.A. has published the list of shareholders holding at least 5% of voting rights at its Ordinary General Meeting, which resumed proceedings on July 16, 2026. This disclosure provides transparency regarding the company's ownership structure and voting control following the meeting's resumption.